Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure

Recruiting

• Conditions: Heart Failure
• Interventions: Other: Mortality and Rehospitalization rate

• Registration Number: NCT04062500
• Lead Sponsor: Shanghai 10th People's Hospital

Brief Summary

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

Detailed Description

Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients.

1. To elucidate the clinical characteristics and prognostic risks of patients with heart failure.

2. To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients.

3. To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects.

4. To investigate the effect of self-management on outcomes in patients with heart failure.

5. To elucidate critical factors associated with the development and outcomes of heart failure.

6. To investigate hospitalization expenses for heart failure.

Study Timeline

• Study Start: 2018-01-01
• Study First Submitted: 2019-08-09
• Study First Submitted QC: 2019-08-19
• Study First Posted: 2019-08-20
• Status Verified: 2020-08
• Last Update Submitted: 2020-08-14
• Last Update Posted: 2020-08-17
• Primary Completion: 2020-12-31
• Study Completion: 2027-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10500

Inclusion Criteria

• 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines.

3. Agree to be tested and sign an informed consent certificate.

Exclusion Criteria

• 1. Age<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with heart failure	Mortality and Rehospitalization rate	patients treated in the hospital for acute heart failure in China

Primary Outcome Measures

Name	Time	Method
Mortality of acute decompensated heart failure	10 years	In-hospital and Annual mortality
Re-hospitalization rate	10 years	Re-hospitalization of acute decompensated heart failure

Trial Locations

Locations (1)

Shanghai Tenth People's Hospital, Tongji University; 🇨🇳 Shanghai, Shanghai, China